Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

AGM Statement

7 Dec 2017 07:00

RNS Number : 6168Y
MJ Gleeson PLC
07 December 2017
 

MJ Gleeson plc

(GLE.L)

 

AGM Statement

 

At the Annual General Meeting of MJ Gleeson plc (GLE.L), the urban regeneration and strategic land specialist, convened for 11:30 am today in Sheffield, the Chairman, Dermot Gleeson, will state:

"Demand at Gleeson Homes remains strong with the forward order book at the end of November up more than 30% on last year.

"Land remains available at sensible prices and the pipeline remains strong. Gleeson Homes has a pipeline of 11,529 plots with a gross development value of £1.4 billion, of which 5,582 plots are owned and 5,947 are conditionally purchased.

"The division currently has 58 active sites, compared with 50 at this time last year and we expect the number of active sites to be approaching 70 by June 2018.

"The Government's Help to Buy scheme remains popular with 63% of our customers taking advantage of it so far this year while other buyers continue to be attracted by our own bespoke purchaser assistance packages.

"The division's increasing number of sales outlets, combined with very strong customer demand in all regions, good mortgage availability and attractive levels of affordability means that the outlook for the division remains very positive.

"The Board expects Gleeson Homes to record an increase in completions for the first half year to 31 December 2017 of more than 15% compared with the prior half year total of 451 units; and for the year to 30 June 2018 of approximately 20% compared with the prior year total of 1,013 units.

"Gleeson Strategic Land continues to experience strong demand for consented land in the first five months of the current financial year, completing the sale of two sites with planning permission for 50 plots and a 60-bed care home and is progressing sale negotiations on a further 10 sites.

"The division's land pipeline currently consists of 63 sites which have the potential to deliver approximately 21,455 plots. The portfolio includes 12 sites with planning permission.

"We expect Gleeson Strategic Land results for the full year June 2018 to be broadly in line with results for the prior financial year. Due to the timing of a site sale the division's results for the first half of the year may fall below those of the prior year. In this event, the second half is likely to be significantly stronger than the first.

"The Board, therefore, remains confident that the result for the full year to 30 June 2018 will be in line with expectations."

 

7 December 2017

This announcement contains inside information.

 

 

Enquiries:

MJ Gleeson plc

Tel: +44 1142 612 900

Jolyon Harrison

Chief Executive Officer

Stefan Allanson

Chief Financial Officer

 

Instinctif Partners

Tel: +44 20 7457 2020

Mark Garraway

Helen Tarbet

James Gray

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Alex Laughton-Scott

Liberum

Neil Patel

Tel: +44 20 3100 2222

Richard Bootle

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMZMMGZNVKGNZM
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.